These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14654006)

  • 21. Increasing number of companies found ineligible for SBIR funding.
    Bouchie A
    Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384
    [No Abstract]   [Full Text] [Related]  

  • 22. The global financial crisis: an acute threat to health.
    Horton R
    Lancet; 2009 Jan; 373(9661):355-6. PubMed ID: 19186260
    [No Abstract]   [Full Text] [Related]  

  • 23. Have charities been silenced by government gold?
    Hawkes N
    BMJ; 2007 Sep; 335(7620):592. PubMed ID: 17884903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colin Blakemore.
    Barbour V
    Lancet; 2003 Nov; 362(9395):1590. PubMed ID: 14615136
    [No Abstract]   [Full Text] [Related]  

  • 25. US budget emphasizes bioterrorism countermeasures.
    Fox JL
    Nat Biotechnol; 2004 Mar; 22(3):256-7. PubMed ID: 14990938
    [No Abstract]   [Full Text] [Related]  

  • 26. Japan budget threat sparks backlash.
    Cyranoski D
    Nature; 2009 Dec; 462(7273):557. PubMed ID: 19956231
    [No Abstract]   [Full Text] [Related]  

  • 27. Biotechs get $1 billion windfall in R&D tax credits.
    Thiel K
    Nat Biotechnol; 2009 Dec; 27(12):1066. PubMed ID: 20010563
    [No Abstract]   [Full Text] [Related]  

  • 28. Proposed changes to 340B program alarm pharmacy chiefs.
    Traynor K
    Am J Health Syst Pharm; 2016 Jan; 73(1):e3-4. PubMed ID: 26683677
    [No Abstract]   [Full Text] [Related]  

  • 29. How to beat HIV.
    Check Hayden E
    Nature; 2015 Jul; 523(7559):146-8. PubMed ID: 26156356
    [No Abstract]   [Full Text] [Related]  

  • 30. Structural genomics: inside a protein structure initiative center.
    Blow N
    Nat Methods; 2008 Feb; 5(2):203-7. PubMed ID: 18235436
    [No Abstract]   [Full Text] [Related]  

  • 31. Commercializing research. NSF program offers start-up 101 to its grantees.
    Mervis J
    Science; 2012 Jul; 337(6092):281. PubMed ID: 22822122
    [No Abstract]   [Full Text] [Related]  

  • 32. Japan launches new life-science initiatives.
    Triendl R
    Nat Biotechnol; 2003 Mar; 21(3):218. PubMed ID: 12610556
    [No Abstract]   [Full Text] [Related]  

  • 33. Little science, big bucks.
    DeFrancesco L
    Nat Biotechnol; 2003 Oct; 21(10):1127-9. PubMed ID: 14520387
    [No Abstract]   [Full Text] [Related]  

  • 34. Brussels backs nanotech.
    Nat Nanotechnol; 2007 Feb; 2(2):65. PubMed ID: 18654212
    [No Abstract]   [Full Text] [Related]  

  • 35. Policy paper highlights concerns about the future of HIV care and its funding.
    Hampton T
    JAMA; 2011 Dec; 306(23):2551-2. PubMed ID: 22187267
    [No Abstract]   [Full Text] [Related]  

  • 36. Italy creates neuroscience network.
    Ballmaier M
    Nat Med; 2000 May; 6(5):490. PubMed ID: 10802689
    [No Abstract]   [Full Text] [Related]  

  • 37. Germany biotech gets second chance.
    Sheridan C
    Nat Biotechnol; 2003 Dec; 21(12):1414-5. PubMed ID: 14647310
    [No Abstract]   [Full Text] [Related]  

  • 38. Building clinical research capacity in China: the National Clinical Research Centres.
    Yang Z; Jiang L
    Lancet; 2014 Jan; 383(9913):200-1. PubMed ID: 24290403
    [No Abstract]   [Full Text] [Related]  

  • 39. Decision Time.
    Lane T
    Ann R Coll Surg Engl; 2018 Jul; 100(6):423. PubMed ID: 29962295
    [No Abstract]   [Full Text] [Related]  

  • 40. Cautious industry welcome for US flu vaccine plan.
    Kling J
    Nat Biotechnol; 2005 Dec; 23(12):1457-8. PubMed ID: 16333275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.